Fenimore Asset Management Inc lowered its position in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 189,900 shares of the business services provider’s stock after selling 1,053 shares during the period. Fenimore Asset Management Inc owned approximately 0.37% of Exponent worth $16,920,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also modified their holdings of the business. Conestoga Capital Advisors LLC boosted its holdings in Exponent by 1.6% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock valued at $323,535,000 after acquiring an additional 43,257 shares during the period. State Street Corp lifted its position in shares of Exponent by 0.7% during the third quarter. State Street Corp now owns 1,840,313 shares of the business services provider’s stock worth $212,151,000 after purchasing an additional 13,644 shares during the last quarter. Geneva Capital Management LLC boosted its stake in shares of Exponent by 1.7% during the third quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after purchasing an additional 27,339 shares during the period. Geode Capital Management LLC boosted its stake in shares of Exponent by 4.8% during the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares during the period. Finally, JPMorgan Chase & Co. boosted its stake in shares of Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.
Exponent Price Performance
Shares of EXPO opened at $92.09 on Friday. The firm has a market capitalization of $4.67 billion, a price-to-earnings ratio of 44.49 and a beta of 0.71. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75. The company has a 50-day moving average of $93.10 and a 200 day moving average of $101.38.
Insider Transactions at Exponent
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also
- Five stocks we like better than Exponent
- What Does Downgrade Mean in Investing?
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
- CD Calculator: Certificate of Deposit Calculator
- MarketBeat Week in Review – 01/20 – 01/24
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.